{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:46:32Z","timestamp":1789001192726,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006778","name":"Georgia Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2023.10.040","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T19:34:42Z","timestamp":1700076882000},"page":"1892-1898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A mixed integer programming model for vaccine pricing within a group purchasing organization"],"prefix":"10.1016","volume":"42","author":[{"given":"Zhuoting","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2686-546X","authenticated-orcid":false,"given":"Pinar","family":"Keskinocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-8209","authenticated-orcid":false,"given":"Walter A.","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7446-8253","authenticated-orcid":false,"given":"L. Beril","family":"Toktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.10.040_b1","series-title":"The 17 sustainable development goals, United Nations","year":"2023"},{"key":"10.1016\/j.vaccine.2023.10.040_b2","series-title":"Operating procedures of the PAHO revolving fund for the purchase of vaccines, syringes, and other related supplies","year":"2023"},{"key":"10.1016\/j.vaccine.2023.10.040_b3","series-title":"2019 Global vaccine market report","year":"2021"},{"key":"10.1016\/j.vaccine.2023.10.040_b4","series-title":"Differential pricing for pharmaceuticals: Review of current knowledge, new findings and ideas for action. U.K. Department for International Development (DFID)","author":"Yadav","year":"2010"},{"key":"10.1016\/j.vaccine.2023.10.040_b5","doi-asserted-by":"crossref","first-page":"D72","DOI":"10.1016\/j.vaccine.2015.09.033","article-title":"Immunization equity","volume":"33","author":"Hinman","year":"2015","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"10.1016\/j.vaccine.2023.10.040_b6","series-title":"GNI per capita, PPP (current international $)","year":"2022"},{"key":"10.1016\/j.vaccine.2023.10.040_b7","series-title":"Immunization, vaccines and biologicals - Immunization financing indicators","year":"2021"},{"key":"10.1016\/j.vaccine.2023.10.040_b8","series-title":"PAHO vaccine prices for year 2020","year":"2021"},{"key":"10.1016\/j.vaccine.2023.10.040_b9","series-title":"Co-financing policy","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.040_b10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1744-8603-7-39","article-title":"A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries","volume":"7","author":"Moon","year":"2011","journal-title":"Glob Health"},{"key":"10.1016\/j.vaccine.2023.10.040_b11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12688\/gatesopenres.13110.3","article-title":"Value-based tiered pricing for universal health coverage: an idea worth revisiting","volume":"4","author":"Chalkidou","year":"2020","journal-title":"Gates Open Res"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.040_b12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1937-5956.2010.01121.x","article-title":"Controversial role of GPOs in healthcare-product supply chains","volume":"20","author":"Hu","year":"2011","journal-title":"Prod Oper Manage"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.040_b13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1287\/msom.1110.0355","article-title":"The impact of group purchasing organizations on healthcare-product supply chains","volume":"14","author":"Hu","year":"2012","journal-title":"Manuf Serv Oper Manag"},{"issue":"7","key":"10.1016\/j.vaccine.2023.10.040_b14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2471\/BLT.08.058925","article-title":"Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases","volume":"87","author":"Waning","year":"2009","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2023.10.040_b15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/nav.20305","article-title":"Collaborative procurement among competing buyers","volume":"55","author":"Keskinocak","year":"2008","journal-title":"Nav Res Logist"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.040_b16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1473-3099(04)01255-1","article-title":"Tiered pricing of vaccines: a win-win-win situation, not a subsidy","volume":"5","author":"Plahte","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.10.040_b17","series-title":"(Mis)Understanding Overhead","year":"2021"},{"key":"10.1016\/j.vaccine.2023.10.040_b18","series-title":"Eligibility and transition policy","year":"2021"},{"key":"10.1016\/j.vaccine.2023.10.040_b19","series-title":"Vaccines and immunization","author":"World Health Organization","year":"2022"},{"issue":"11","key":"10.1016\/j.vaccine.2023.10.040_b20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1365-3156.2001.00801.x","article-title":"Pricing of drugs and donations: options for sustainable equity pricing","volume":"6","author":"P\u00e9rez-Casas","year":"2001","journal-title":"Trop Med Int Health"},{"issue":"9323","key":"10.1016\/j.vaccine.2023.10.040_b21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(02)08911-0","article-title":"Differential pricing of drugs: a role for cost-effectiveness analysis?","volume":"359","author":"Lopert","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.10.040_b22","series-title":"GAVI approach creates tiered pricing for vaccines","year":"2022"},{"issue":"9936","key":"10.1016\/j.vaccine.2023.10.040_b23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0140-6736(13)62424-1","article-title":"Improving access to vaccines through tiered pricing","volume":"383","author":"Berkley","year":"2014","journal-title":"Lancet"},{"issue":"9946","key":"10.1016\/j.vaccine.2023.10.040_b24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(14)61483-5","article-title":"Is tiered pricing the way for vaccines?","volume":"384","author":"Balasegaram","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.10.040_b25","series-title":"Global vaccine differential pricing approach","year":"2022"},{"key":"10.1016\/j.vaccine.2023.10.040_b26","series-title":"GSK Public policy positions - Tiered pricing and vaccines","year":"2022"},{"issue":"5","key":"10.1016\/j.vaccine.2023.10.040_b27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004823","article-title":"Health spending and vaccination coverage in low-income countries","volume":"6","author":"Castillo-Zunino","year":"2021","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.vaccine.2023.10.040_b28","series-title":"Immunization financing indicators","year":"2021"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.040_b29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hec.3013","article-title":"Pharmaceutical pricing in emerging markets: Effects of income, competition, and procurement","volume":"24","author":"Danzon","year":"2015","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2023.10.040_b30","series-title":"PAHO revolving fund","year":"2023"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23012239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23012239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T08:54:27Z","timestamp":1728809667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23012239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X23012239"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mixed integer programming model for vaccine pricing within a group purchasing organization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}